{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:12:56Z","timestamp":1792699976223,"version":"4.5.0"},"reference-count":104,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1080\/14740338.2024.2392007","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T07:38:50Z","timestamp":1723448330000},"page":"1115-1126","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis"],"prefix":"10.1080","volume":"23","author":[{"given":"Teresa","family":"Battista","sequence":"first","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Picone","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Noto","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-0592","authenticated-orcid":false,"given":"Luca","family":"Potestio","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ruggiero","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-050X","authenticated-orcid":false,"given":"Fabrizio","family":"Martora","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Megna","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Genco","sequence":"additional","affiliation":[{"name":"Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.2007"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S364640"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01101-6"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S400679"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12817"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/12034754231188444"},{"issue":"7","key":"e_1_3_6_10_1","first-page":"695","article-title":"Injection site reactions to biologic agents used in psoriasis and psoriatic arthritis","volume":"16","author":"Henderson Berg MH","year":"2017","unstructured":"Henderson Berg MH, Carrasco D. Injection site reactions to biologic agents used in psoriasis and psoriatic arthritis. J Drugs Dermatol. 2017 Jul 1;16(7):695\u2013698.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.9.1190"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01058.x"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-00341-2"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13803"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573397118666220829123713"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.139924"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/PG9.0000000000000016"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-016-0041-3"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1520426"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.020"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.10.031"},{"key":"e_1_3_6_22_1","volume-title":"StatPearls [internet]","author":"Pan A","year":"2024","unstructured":"Pan A, Gerriets V. Etanercept. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan [cited 2023 Jul 24]. PMID: 31424836."},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630410017275"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh413"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2012.727796"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.02945.x"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.755957"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.2165\/1153426-S0-000000000-00000"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2019.1614561"},{"key":"e_1_3_6_30_1","unstructured":"COSENTIX. Secukinumab (COSENTIX) - prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761349s000lbl.pdf"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.862508"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13348"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2021.1902925"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314258"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17002"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1551-x"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212687"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30564-X"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222849"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15958"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01352-8"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13893"},{"key":"e_1_3_6_43_1","unstructured":"TALTZ. Ixekizumab (TALTZ) - prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/125521s014lbl.pdf"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.09.026"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60125-8"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez684"},{"issue":"2","key":"e_1_3_6_48_1","first-page":"200","article-title":"Safety and tolerability of Ixekizumab: integrated analysis of injection-site reactions from 11 clinical trials","volume":"17","author":"Shear NH","year":"2018","unstructured":"Shear NH, Paul C, Blauvelt A, et al. Safety and tolerability of Ixekizumab: integrated analysis of injection-site reactions from 11 clinical trials. J Drugs Dermatol. 2018;17(2):200\u2013206.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011535.pub5"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32971-X"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1512711"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31429-0"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19147"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13622"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_786_17"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418814229"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15288"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14790"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14066"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02126-0"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12304"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_271.x"},{"issue":"1","key":"e_1_3_6_63_1","first-page":"41","article-title":"Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta","volume":"49","author":"Veys N","year":"1998","unstructured":"Veys N, Dhondt A, Lameire N. Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta. Clin Nephrol. 1998;49(1):41\u201344.","journal-title":"Clin Nephrol"},{"key":"e_1_3_6_64_1","unstructured":"SILIQ. Brodalumab (SILIQ) - prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/761032lbl.pdf"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15667"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14493"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503824"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.04.648"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00472-x"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000002170"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.094"},{"key":"e_1_3_6_72_1","unstructured":"BIMZELX. Bimekizumab (BIMZELX)- prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761151s000lbl.pdf"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1243843"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15543"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2218086"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13185"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02303-0"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.04.063"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223595"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.2905"},{"key":"e_1_3_6_81_1","unstructured":"TREMFYA. Guselkumab (TREMFYA) - prescribing information. Availaible from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/761061s007lbl.pdf"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30265-8"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30263-4"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.041"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15750"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19509"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00851-6"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16511"},{"key":"e_1_3_6_89_1","unstructured":"SKYRIZI. Risankizumab (SKYRIZI) - prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/761105s014lbl.pdf"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093233"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20595"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00795-x"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020495"},{"key":"e_1_3_6_94_1","unstructured":"ILUMYA. Tildrakizumab (ILUMYA) - prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/761067s014lbl.pdf"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15030"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2022.2160447"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31279-5"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP202176"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13001"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16724"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S402183"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2173170"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2173171"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2023.2219387"},{"key":"e_1_3_6_105_1","unstructured":"CIMZIA. CIMZIA (Certolizumab pegol) - prescribing information. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/cimzia-epar-product-information_en.pdf"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1839007"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11061718"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2392007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T14:13:19Z","timestamp":1732889599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2392007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":104,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1080\/14740338.2024.2392007"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2392007","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-02-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}